Cibc Private Wealth Group, LLC Moderna, Inc. Transaction History

Cibc Private Wealth Group, LLC

$56.1 Billion
Q3 2025

A detailed history of Cibc Private Wealth Group, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 7,639 shares of MRNA stock, worth $189,141. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,639

Previous 6,726 13.57%

Holding current value

$189,141

Previous $190,000 3.68%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 21, 2025	BUY	$23.51 - $34.67 $21,464 - $31,653	913 Added 13.57%	7,639 $197,000
Q1 2025 May 14, 2025	SELL	$28.35 - $47.53 $9,072 - $15,209	-320 Reduced 4.54%	6,726 $190,000
Q4 2024 Feb 12, 2025	BUY	$36.85 - $63.93 $109,776 - $190,447	2,979 Added 73.25%	7,046 $292,000
Q3 2024 Nov 13, 2024	SELL	$63.64 - $125.14 $58,803 - $115,629	-924 Reduced 18.51%	4,067 $271,000
Q2 2024 Aug 09, 2024	SELL	$101.21 - $166.61 $187,946 - $309,394	-1,857 Reduced 27.12%	4,991 $592,000

Q1 2024 May 10, 2024	BUY	$85.37 - $115.44 $339,772 - $459,451	3,980 Added 138.77%	6,848 $729,000
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $199,354 - $299,505	2,868 New	2,868 $285,000
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $322,684 - $423,763	3,347 New	3,347 $345,000
Q2 2023 Nov 21, 2023	BUY	$118.5 - $160.53 $235,104 - $318,491	1,984 New	1,984 $241,000
Q2 2023 Aug 10, 2023	SELL	$118.5 - $160.53 $40,882 - $55,382	-345 Reduced 14.81%	1,984 $241,000
Q1 2023 Nov 21, 2023	BUY	$135.66 - $197.02 $315,952 - $458,859	2,329 New	2,329 $357,000
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $1.12 Million - $1.62 Million	-8,244 Reduced 77.97%	2,329 $357,000
Q4 2022 Jun 01, 2023	BUY	$118.38 - $210.04 $1.25 Million - $2.22 Million	10,573 New	10,573 $1.9 Million
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $1.01 Million - $1.78 Million	8,496 Added 409.05%	10,573 $1.9 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $16,529 - $27,185	-140 Reduced 6.31%	2,077 $246,000
Q2 2022 Aug 03, 2022	SELL	$117.13 - $176.59 $636,133 - $959,060	-5,431 Reduced 71.01%	2,217 $316,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $681,998 - $1.27 Million	5,393 Added 239.16%	7,648 $1.32 Million
Q4 2021 Feb 08, 2022	SELL	$225.82 - $368.51 $235,304 - $383,987	-1,042 Reduced 31.6%	2,255 $573,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $143,125 - $312,483	645 Added 24.32%	3,297 $1.27 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $10,392 - $18,798	80 Added 3.11%	2,652 $623,000
Q1 2021 May 12, 2021	BUY	$109.18 - $185.98 $3,712 - $6,323	34 Added 1.34%	2,572 $337,000
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $166,848 - $431,104	2,538 New	2,538 $265,000
Q2 2020 Aug 13, 2020	SELL	$29.67 - $80.0 $705,048 - $1.9 Million	-23,763 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $422,506 - $750,435	23,763 New	23,763 $712,000

Others Institutions Holding MRNA

# of Institutions

844

Shares Held

257M

Call Options Held

39.6M

Put Options Held

43.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $9.69B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Account

Cibc Private Wealth Group, LLC Moderna, Inc. Transaction History